Physician

Joshua Michael Larned, M.D.

According to 2025 Medicare claims, Joshua Larned, M.D. (NPI: 1023293537) practices advanced heart failure and transplant cardiology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is HOLY CROSS HOSPITAL INC (NPI: 1467401877; TIN: 590791028) and primary practice location at 33308-4603.

Larned's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,851 traditional Medicare patients, billed 5,223 HCPCS/CPT codes, and received $256,161 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,731 prescription claims across 801 beneficiaries totaling $624,746 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 176 claims. Open Payments data shows 35 records totaling $72,733. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $338,928 to $624,746. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,753	5,373	$237,907
2016	1,588	5,010	$206,063
2017	1,702	5,274	$221,038
2018	1,695	5,198	$224,442
2019	1,637	5,117	$245,833
2020	1,556	4,642	$216,003
2021	1,655	5,094	$262,090
2022	1,710	4,765	$227,717
2023	1,691	4,682	$237,397
2024	1,851	5,223	$256,161

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	585	3,749	$338,928
2016	522	2,267	$240,480
2017	453	1,726	$205,893
2018	504	1,732	$261,477
2019	645	2,729	$449,032
2020	502	1,638	$286,974
2021	682	2,629	$483,372
2022	905	4,650	$1,058,802
2023	1,024	5,590	$1,440,269
2024	801	2,731	$624,746

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	199	$13,580
2019	N/R	176	$9,497
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	140	160	$137
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,057	1,725	$71
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	510	543	$51
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	199	210	$47
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	918	1,041	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	214	13,145	$249,290
Xarelto	Rivaroxaban	100	6,040	$105,906
Entresto	Sacubitril/Valsartan	62	3,350	$72,765
Jardiance	Empagliflozin	57	2,906	$56,450
Repatha Sureclick	Evolocumab	47	2,802	$53,482

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$16,152	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	9	$56,581	Holy Cross Hospital
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joshua Michael Larned, M.D.?

Tedicare shows public-source Medicare data for Joshua Michael Larned, M.D. (NPI 1023293537), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua Michael Larned, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joshua Michael Larned, M.D.?

Joshua Michael Larned, M.D. is linked to HOLY CROSS HOSPITAL INC (billing NPI 1467401877) in the available physician profile data.

Does Joshua Michael Larned, M.D. have Open Payments data?

Joshua Michael Larned, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.